Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology

• Egile Nagusiak: Kailin Yang (Egilea), Liuting Zeng (Egilea), Anqi Ge (Egilea), Tingting Bao (Egilea), Tao Xu (Egilea), Xiaobing Xie (Egilea), Lifang Liu (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundXihuang Pill (XHP) is mainly used to treat "Ru Yan (breast cancer)". Evidence-based medical evidence and showed that XHP improves the efficacy of chemotherapy and reduced chemotherapy-induced toxicity in breast cancer patients. However, the mechanism of XHP against breast cancer...